3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
A protocol for using PT-141 (Bremelanotide) in executive longevity stacks targeting sexual health, sleep, cognition, and body composition. Covers dosing, frequency, cycle length, labs, and evidence quality.
A structured clinical protocol for using PT-141 (Bremelanotide) in ACL and ligament rehabilitation, covering dosing, timing, monitoring, and the evidence base behind melanocortin receptor signaling in connective tissue repair.
An evidence-boundary review of off-label PT-141 (Bremelanotide) use in combat sports, covering what is FDA-approved, what animal and case-series evidence shows, and a clinician-discussion framework for monitoring and escalation.